According to a recent LinkedIn post from Hazel Health, an independent 2023 evaluation by Clemson University of the company’s H.E.A.R.T. teletherapy program reportedly found that 75% of participating students experienced a clinically significant reduction in depression and anxiety. The post notes that these gains were consistent across demographic groups, and partner districts have observed attendance improvements of up to 11 additional days in school for students receiving care.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that Hazel Health is positioning its school-based teletherapy offering as both an academic and mental health intervention, which may strengthen its value proposition to K-12 districts facing student well-being and absenteeism challenges. For investors, independently evaluated outcomes and reported attendance gains could support future district renewals, expansion into new geographies, and potential pricing power, while also reinforcing the company’s competitive standing in the growing market for school-based behavioral health services.

